Magenta Elevate™ Clinical Feasibility Study in Cardiogenic Shock
NCT: NCT07293923 · RECRUITING
NCT IDNCT07293923
StatusRECRUITING
Start Date2025-11-05
Completion2028-02-28
SponsorMagenta Medical Ltd. (INDUSTRY)
First posted
Last updated
Brief Summary
The Elevate™ CS Clinical Feasibility Study is designed to evaluate the initial safety, effectiveness, and device performance of the Magenta Elevate™ System in patients with cardiogenic shock due to isolated or predominant left ventricular failure.
Frequently Asked Questions
What is Magenta Elevate™ Clinical Feasibility Study in Cardiogenic Shock?
Magenta Elevate™ Clinical Feasibility Study in Cardiogenic Shock is a clinical trial registered under NCT07293923. Current status: RECRUITING.
What is the status of NCT07293923?
The current status of NCT07293923 (Magenta Elevate™ Clinical Feasibility Study in Cardiogenic Shock) is: RECRUITING.
When did Magenta Elevate™ Clinical Feasibility Study in Cardiogenic Shock start?
Magenta Elevate™ Clinical Feasibility Study in Cardiogenic Shock started on 2025-11-05.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.